Tractivus’ technology is designing new medical devices, like bioactive trachea prosthesis, to increase the adaptability and the interaction with the surrounding tissues of the body.
Tractivus is dedicated to develop new personalized medical devices with bioactive surfaces while providing cost effect healthcare solutions that revolutionize the current implantable devices and the gold standard treatments.
Tractivus’ mission is to increase the life quality of patients, avoid post-implantation complications and to give a drug delivery solution that treats the pathology directly.
Overview
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Tractivus abre una ronda de financiación en Capital Cell para llevar su tecnología al mercado |
Reviews 0
FAQ about Tractivus SL
When was Tractivus SL founded?
Tractivus SL was founded in 2015.
How much funding has Tractivus SL raised?
Tractivus SL has raised $490.44K in total across 1 funding round.
What has the press written about Tractivus SL?
Parsers VC has collected 2 articles mentioning Tractivus SL, among them “Tractivus abre una ronda de financiación en Capital Cell para llevar su tecnología al mercado”.
Is Tractivus SL still active?
Yes, Tractivus SL is active; its latest activity on Parsers VC dates from Nov 16, 2018.